RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Meloxicam

Osteoarthritis (OA), Rheumatoid Arthritis (RA), Juvenile Rheumatoid Arthritis (JRA) in patients who weigh ≥60 kg

Boxed warning

  • WARNING: RISK OF SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL EVENTS Cardiovascular Thrombotic Events Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use [see Warnings and Precautions (5.1) ] . Meloxicam is contraindicated in the setting of coronary artery bypass graft (CABG) surgery [see Contraindications (4) and ... (see full label)

Indications

  • Osteoarthritis (OA)
  • Rheumatoid Arthritis (RA)
  • Juvenile Rheumatoid Arthritis (JRA) in patients who weigh ≥60 kg

Adult dosing

  • oa ra: dose: 7.5; unit: mg; route: PO; interval: once daily (range 7.5 to 15 mg); fixed: true; labelExcerpt: For the relief of the signs and symptoms of osteoarthritis the recommended starting and maintenance oral dose of meloxicam tablets is 7.5 mg once daily. Some patients may receive additional benefit by increasing the dose to 15 mg once daily.

Pediatric dosing

  • jra: dose: 7.5; unit: mg; route: PO; interval: once daily; fixed: true; labelExcerpt: For the treatment of juvenile rheumatoid arthritis, the recommended oral dose of meloxicam is 7.5 mg once daily in children who weigh ≥60 kg. There was no additional benefit demonstrated by increasing the dose above 7.5 mg in clinical trials.

Renal adjustment

  • failure: 7.5 mg max; hemodialysis: 7.5 mg max; note: Use not recommended in severe impairment. In hemodialysis, max 7.5 mg daily. Label: "In patients on hemodialysis, the maximum dosage of meloxicam tablets is 7.5 mg per day [see Clinical Pharmacology (12.3) ]."

Hepatic adjustment

  • Monitor function; discontinue if clinical signs/symptoms of liver disease develop or abnormal liver tests persist.

Contraindications

  • Known hypersensitivity to meloxicam
  • History of asthma/urticaria after aspirin/NSAID use
  • Coronary artery bypass graft (CABG) surgery

Clinical pearls

  • Use lowest effective dose for shortest duration.
  • Not interchangeable with other oral meloxicam formulations.
  • Monitor renal function, blood pressure, and hemoglobin/hematocrit.
  • Discontinue immediately if skin rash or hypersensitivity signs occur.

Source and review

  • DailyMed label (meloxicam), Set ID 2322a070-25f0-4fc6-a98e-44ad1fb52dc5, effective 2026-10-19. Last reviewed: 2026-11-11